Ann: A$18.7m Osteopore, NDCS and A*STAR project hits milestones, page-23

You do feature a bit on these forums trying to cast doubt on OSX' announcements. For example when OSX similar announced the beginning of human trials with A*Star:


You were quick to ask why "not sure why their trials are not in the gold standard countries." Rather ignoring the fact, that bar Liechenstein and Luxembourg, Singapore probably the wealthiest country in terms of GDP per capita and its where its business headquarters based and has been advancing itself as the bio-tech centre of Asia for 20 years:

"In 2000, the government in Singapore made biomedical research the fourth pillar of the city’s state economy, known as the National Biomedical Science Strategy. Then, in 2003, under the initiative, the country established Biopolis, which is a custom-built biomedical R&D hub. Over the next 20 years or so, billions of dollars were invested in the life sciences sector."

https://www.labiotech.eu/best-biotech/biotech-companies-singapore/#:~:text=Singapore%20set%20out%20to%20become,that%20includes%20numerous%20biotech%20companies.

This is just one aspect of the collaboration in research that OSX has with A*Star (and now SingHealth) that people would rather ignorantly comment on than actually exploring what the collaboration involves. Lets help you and the others out:

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02654262-6A114510

The official ASX release on OSX's binding agreement with A*Star in regenerative tissue trials that recently commenced human trials,


And of course the original ASX release to this latest notice:


Here you go so you and others can read up on just some of those collaborations and trials OSX has going on in that 'non-gold class' with the country's research agency that is a bit of a titan in SE Asia bio-tech research:

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02465768-6A1068295

Oh and the rather important SingHealth collaboration as well in case you missed it:

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02806540-6A1207423

(and there are commercial collaborations should you be ignorant of those - all there in the ASX releases)

I feel its perhaps important for people like yourself, who ignorantly dismiss Singapore as not being a "gold-class country" that Singapore, very much propelled by A*Star's (the government agency for R&D essentially) public and private collaborations, to understand on practically every index of innovation Singapore is usually 1st, 2nd or 3rd in global innovation index rankings:




...and OSX very much in bed with the driving force of that innovation....